Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
University of Nebraska
Eli Lilly and Company
Massive Bio, Inc.
Pfizer
Eli Lilly and Company
AbbVie
Inova Health Care Services
Daiichi Sankyo
Memorial Sloan Kettering Cancer Center
Avera McKennan Hospital & University Health Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
BBB-Therapeutics B.V.
Yale University
University of California, San Francisco
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Novartis
Tufts Medical Center
National Institutes of Health Clinical Center (CC)